Iovance Biotherapeutics Inc. sell melinda
Start price
06.06.16
/
50%
€8.15
Target price
18.08.16
€6.00
Performance (%)
10.33%
End price
18.08.16
€8.99
Summary
This prediction ended on 18.08.16 with a price of €8.99. The prediction closed with a disappointing performance of 10.33%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 5.140% | 5.140% | -77.202% | -70.551% |
| iShares Core DAX® | 1.659% | 1.586% | 18.113% | 65.562% |
| iShares Nasdaq 100 | 0.381% | 1.900% | 8.877% | 103.178% |
| iShares Nikkei 225® | 2.102% | -1.377% | 13.281% | 43.551% |
| iShares S&P 500 | 0.221% | 1.258% | 3.556% | 63.162% |
According to melinda what are the pros and cons of Iovance Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Lion Biotechnologies Inc diskutieren
wieder zu Hause!
folgen
(Vom Mitglied beendet)
Stopped prediction by melinda for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.68
11.05.25
11.05.25
-
11.05.26
11.05.26
-3.81%
24.05.25
24.05.25
Could be worthwhile Investment >10% per year
